GlassScriptPhysician profile
Kynan D Williams
NPI 1497908495
$14,349.95
in general payments reported to CMS, 2019-2025
19 companies · $15.15 in 2025
The $15.15 reported for 2025 was less than what a typical Family Medicine provider received nationally (typical 2025 total: $153).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $142 · 2020: $358 · 2021: $134 · 2022: $302 · 2023: $13K · 2025: $15.15.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Debt Forgiveness: $13K · Food and Beverage: $15.15.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Debt Forgiveness | $13,398.10 |
| Food and Beverage | $15.15 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Angiodynamics, INC. | $13,398.10 | 2023 | Venacure Evlt |
| Gm Pharmaceuticals, INC. | $293.14 | 2020 | |
| Novo Nordisk INC | $119.21 | 2022 | |
| Phadia US INC. | $64.43 | 2019 | |
| Mdd US Operations, LLC | $52.95 | 2019-2020 | |
| Cranial Technologies, INC | $52.87 | 2021-2022 | |
| Amgen INC. | $48.31 | 2020-2021 | |
| Sanofi Pasteur INC. | $43.92 | 2019-2022 | |
| Pfizer INC. | $39.89 | 2022 | |
| Bayer Healthcare Pharmaceuticals INC. | $39.83 | 2022 | |
| Supernus Pharmaceuticals, INC. | $34.21 | 2021-2022 | |
| Paratek Pharmaceuticals, INC. | $34.20 | 2021 | |
| Glaxosmithkline, LLC. | $33.17 | 2022 | |
| Hologic Sales and Service, LLC | $18.62 | 2019 | |
| Nabriva Therapeutics, Plc | $17.28 | 2022 |
Show all 19 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abbott Laboratories | $16.41 | 2021 | |
| Merck Sharp & Dohme LLC | $15.58 | 2019 | |
| Cashflow Solutions, LLC | $15.15 | 2025 | Pcd-52 737a (US) White, Lympha Press Optimal Plus(US) Bt, Pcd-51 731a (US) - White |
| Uswm, LLC | $12.68 | 2021 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Kynan Williams listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.